PremiumMRK

MRK: an overreaction to earnings?

The company published 2025 EPS guidance 2% below consensus due to lower-than-expected sales of the GARADASIL vaccine in China, and the stock fell by 11%.

By the SpyStocks desk · 1y ago · 1 min read

The rest of this story is for members

The rest is for members

The story continues: the full timeline, the transaction ranges, and the names the forms carry.

Premium comes through the Telegram channel. Already have a code? Sign in to activate it.

Telegram@TheAmericanDream5

Hot stock alerts, straight to Telegram

Real-time buys, sweeps, and trading halts from the desk. Free to join.

Join the channel

MRK: an overreaction to earnings?

The rest is for members

Hot stock alerts, straight to Telegram

Related Stories

IREN: options whales predicted the decline

IREN: options whales predicted the decline

Nvidia jumps: partnership with Amazon and cancellation of stock sale

Nvidia jumps: partnership with Amazon and cancellation of stock sale

TTMI stock jumps 15%

TTMI stock jumps 15%